| Autor: |
Mamai M; Institute of Nuclear & Radiological Sciences and Technology, Energy & Safety, National Centre for Scientific Research 'Demokritos', 15341 Athens, Greece.; Institute of Nanoscience & Nanotechnology, National Centre for Scientific Research 'Demokritos', 15341 Athens, Greece., Giasafaki D; Institute of Nanoscience & Nanotechnology, National Centre for Scientific Research 'Demokritos', 15341 Athens, Greece., Salvanou EA; Institute of Nuclear & Radiological Sciences and Technology, Energy & Safety, National Centre for Scientific Research 'Demokritos', 15341 Athens, Greece., Charalambopoulou G; Institute of Nuclear & Radiological Sciences and Technology, Energy & Safety, National Centre for Scientific Research 'Demokritos', 15341 Athens, Greece., Steriotis T; Institute of Nanoscience & Nanotechnology, National Centre for Scientific Research 'Demokritos', 15341 Athens, Greece., Bouziotis P; Institute of Nuclear & Radiological Sciences and Technology, Energy & Safety, National Centre for Scientific Research 'Demokritos', 15341 Athens, Greece. |
| Abstrakt: |
The use of ordered mesoporous matrices, and in particular carbon-based mesoporous nanoparticles has shown great potential towards enhancing the bioavailability of orally administered drugs. Nevertheless, elucidation of the in vivo absorption, distribution, and excretion of such carriers is essential for understanding their behaviour, and radiolabelling provides a very useful way to track their occurrence inside the body. In this work, uniform spherical CMK-1-type ordered mesoporous carbon nanoparticles have been radiolabelled with Technetium-99m ( 99m Tc) and traced after oral administration to mice. Ex vivo biodistribution studies showed that the radiolabelled nanoparticles accumulated almost exclusively in the gastrointestinal tract; complete elimination of the radiotracer was observed within 24 h after administration, with practically no uptake into other main organs. These findings along with the results from in vitro stability studies indicate that the spherical carbon nanoparticles examined could be safely used as drug carriers with minimal side effects, but also support the great value of radiolabelling methods for monitoring the particles' behaviour in vivo. |
